Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Operating Expenses (2024 - 2025)

Connect Biopharma Holdings' Operating Expenses history spans 2 years, with the latest figure at $17.7 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 17.44% year-over-year to $17.7 million; the TTM value through Sep 2025 reached $52.9 million, up 38.67%, while the annual FY2024 figure was $48.5 million, 29.79% down from the prior year.
  • Operating Expenses for Q3 2025 was $17.7 million at Connect Biopharma Holdings, up from $13.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $17.7 million in Q3 2025 and bottomed at $10.3 million in Q4 2024.